BHARAT PARENTERALS
|
BHARAT PARENTERALS Last 5 Year Financial Ratios History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 42.14 | 36.89 | 35.27 | 45.90 | 39.40 |
CEPS(Rs) | 52.27 | 48.43 | 45.80 | 56.17 | 50.09 |
DPS(Rs) | 0.75 | - | - | - | - |
Book NAV/Share(Rs) | 329.94 | 287.72 | 250.47 | 214.92 | 168.95 |
Tax Rate(%) | 24.35 | 24.90 | 25.20 | 24.75 | 37.15 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 8.52 | 11.79 | 10.63 | 13.17 | 13.74 |
EBIT Margin(%) | 13.74 | 12.32 | 11.74 | 15.83 | 16.75 |
Pre Tax Margin(%) | 12.73 | 11.77 | 11.42 | 15.44 | 16.35 |
PAT Margin (%) | 9.63 | 8.84 | 8.54 | 11.62 | 10.28 |
Cash Profit Margin (%) | 11.94 | 11.61 | 11.09 | 14.22 | 13.06 |
Performance Ratios | |||||
ROA(%) | 9.25 | 10.29 | 10.40 | 14.88 | 15.44 |
ROE(%) | 13.65 | 13.76 | 15.16 | 23.92 | 26.38 |
ROCE(%) | 16.62 | 17.59 | 19.80 | 31.68 | 39.83 |
Asset Turnover(x) | 0.96 | 1.16 | 1.22 | 1.28 | 1.50 |
Sales/Fixed Asset(x) | 3.44 | 3.35 | 3.80 | 4.37 | 4.66 |
Working Capital/Sales(x) | 3.82 | 2.34 | 2.23 | 3.21 | 3.66 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.29 | 0.30 | 0.26 | 0.23 | 0.21 |
Receivable days | 134.17 | 106.98 | 115.35 | 118.81 | 103.48 |
Inventory Days | 42.32 | 32.72 | 38.67 | 39.35 | 29.52 |
Payable days | 93.53 | 65.32 | 93.74 | 92.14 | 75.17 |
Valuation Parameters | |||||
PER(x) | 7.97 | 9.25 | 9.50 | 3.09 | 5.58 |
PCE(x) | 6.43 | 7.05 | 7.32 | 2.52 | 4.39 |
Price/Book(x) | 1.02 | 1.19 | 1.34 | 0.66 | 1.30 |
Yield(%) | 0.22 | - | - | - | - |
EV/Net Sales(x) | 1.07 | 0.98 | 0.99 | 0.32 | 0.54 |
EV/Core EBITDA(x) | 5.72 | 5.71 | 5.98 | 1.74 | 2.77 |
EV/EBIT(x) | 6.69 | 6.99 | 7.27 | 2.03 | 3.23 |
EV/CE(x) | 0.75 | 0.95 | 1.03 | 0.38 | 0.74 |
M Cap / Sales | 0.89 | 0.93 | 0.94 | 0.36 | 0.57 |
Growth Ratio | |||||
Net Sales Growth(%) | 2.81 | 4.10 | -10.01 | 3.02 | 61.14 |
Core EBITDA Growth(%) | 11.69 | 7.47 | -18.92 | -2.83 | 111.53 |
EBIT Growth(%) | 17.06 | 6.82 | -22.44 | -2.64 | 150.00 |
PAT Growth(%) | 14.24 | 5.41 | -23.16 | 16.51 | 123.51 |
EPS Growth(%) | 14.24 | 4.59 | -23.16 | 16.51 | 123.51 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | 0.24 | 0.09 | 0.09 | 0.01 | 0.05 |
Current Ratio(x) | 1.61 | 3.57 | 3.58 | 2.07 | 2.00 |
Quick Ratio(x) | 1.26 | 3.05 | 3.03 | 1.65 | 1.65 |
Interest Cover(x) | 13.54 | 22.73 | 36.56 | 41.48 | 42.43 |
Total Debt/Mcap(x) | 0.24 | 0.08 | 0.06 | 0.02 | 0.04 |
Compare Financial Ratios of peers of BHARAT PARENTERALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BHARAT PARENTERALS | ₹650.9 Cr | -1.6% | 9.5% | 243.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹388,812.0 Cr | 3% | 2.3% | 68.2% | Stock Analytics | |
CIPLA | ₹120,673.0 Cr | 2.5% | 0.4% | 71.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,679.0 Cr | -0.2% | -4.9% | 40.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,152.0 Cr | 5% | 10.4% | 109.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹91,234.9 Cr | -1.6% | -7% | 23.8% | Stock Analytics |
BHARAT PARENTERALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BHARAT PARENTERALS | -1.6% |
9.5% |
243.4% |
SENSEX | -0.4% |
-0.9% |
25.8% |
You may also like the below Video Courses